相关实验视频
Updated: Mar 2, 2026

05:07
Microwave-Assisted Preparation of 1-Aryl-1H-pyrazole-5-amines
Published on: June 23, 2019
7.1K
在帕金森病中探索基于Pyrazole的支架的治疗潜力:最近的进展和SAR洞察力
Saurabh Sharma1, Deepika Paliwal1, Aman Thakur2
1Department of Pharmacy, School of Medical & Allied Science, Galgotias University, Greater Noida, Uttar Pradesh, India.
Medicinal chemistry (Shariqah (United Arab Emirates))
|March 1, 2026
概括
皮拉衍生物通过提供神经保护和控制症状来治疗帕金森病 (PD) 是有前途的. 对这些化合物的进一步研究可能会为PD患者改善治疗选择.
科学领域:
- 药用化学 医学化学
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 帕金森病 (PD) 是一种进展性神经退行性疾病,影响全球数百万人,其特点是运动和非运动症状.
- 目前PD的治疗方法提供症状缓解,但不能阻止疾病的进展,需要新的治疗策略.
- 目前正在探索具有多样化药理作用的小分子,而pyrazole衍生物则成为有前途的候选物.
研究的目的:
- 审查皮拉衍生物在治疗帕金森病中的当前应用.
- 突出这些化合物的神经保护潜力和症状调节作用.
- 探索结构-活性关系,以优化基于皮拉的PD治疗方法.
主要方法:
- 文学评论最近的进步在pyrazole衍生物合成和PD的应用.
- 对研究的分析,重点关注与PD病变发生相关的pyrazole衍生物的药理作用.
- 检查结构-活性关系,以指导开发更有效的化合物.
主要成果:
- 皮拉衍生物在影响PD关键病理过程方面具有潜力,包括氧化应激和神经炎症.
- 皮拉结构的修改可以显著提高化合物的活性和选择性.
- 这些衍生物显示出神经保护和改善PD的运动和非运动症状的希望.
结论:
- 皮拉衍生物代表了一类可行的化合物,用于开发新的帕金森病治疗方法.
- 基于结构-活性关系的有针对性的修改可以优化治疗疗效.
- 继续在这一领域的研究对于推动PD管理和患者的治疗结果至关重要.
相关概念视频
Parkinson's Disease: Treatment
1.3K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.3K
Parkinson's Disease: Overview
2.2K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.2K
Structure-Activity Relationships and Drug Design
1.9K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.9K
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
2.3K
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
2.3K
Antipsychotic Drugs: Typical and Atypical Agents
1.1K
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
1.1K
Drug Therapy
333
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
333

